Clinical Trials Directory

Trials / Completed

CompletedNCT05088512

The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population

Preventive and Personalized Medicine (2021-2023)

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Asfendiyarov Kazakh National Medical University · Academic / Other
Sex
All
Age
5 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To research for a genetic marker of bronchial asthma, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with bronchial asthma and normal control will be performed.

Detailed description

Unrelated Kazaks subjects who have bronchial asthma were recruited in the current study. Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with bronchial asthma and normal control subjects free of bronchial asthma

Conditions

Interventions

TypeNameDescription
GENETICSNP analysis of the DNASNP analysis of the DNA obtained from peripheral blood sample

Timeline

Start date
2021-10-23
Primary completion
2023-01-20
Completion
2023-01-20
First posted
2021-10-22
Last updated
2023-03-14

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05088512. Inclusion in this directory is not an endorsement.